Skip to main content
SpringerLink
Log in

Organ-Preserving Strategies in the Management of Fulminant Clostridium difficile Colitis

  • Chapter
  • First Online:
The SAGES Manual of Colorectal Surgery

  • 1251 Accesses

Abstract

The current gold standard treatment for fulminant Clostridium difficile colitis (FCDC) is total abdominal colectomy with end ileostomy. Due to the radical nature of this operation, it is often left as a last resort and results in significant morbidity and mortality. It has become apparent that earlier time to operation is key to improving outcomes. Given the importance of early intervention and reduction in surgical stress, minimally invasive colon preserving therapies and non-operative interventions have emerged as attractive options.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–34.

    Article  CAS  PubMed  Google Scholar 

  2. Kelly CP, LaMont JT. Clostridium difficile—more difficult than ever. N Engl J Med. 2008;359(18):1932–40.

    Article  CAS  PubMed  Google Scholar 

  3. Halabi WJ, Nguyen VQ, Carmichael JC, Pigazzi A, Stamos MJ, Mills S. Clostridium difficile colitis in the United States: a decade of trends, outcomes, risk factors for colectomy, and mortality after colectomy. J Am Coll Surg. 2013;217(5):802–12.

    Article  PubMed  Google Scholar 

  4. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999–2007. Clin Infect Dis. 2012;55(2):216–23.

    Article  PubMed  Google Scholar 

  5. Bhangu A, Nepogodiev D, Gupta A, Torrance A, Singh P, Collaborative WMR. Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis. Br J Surg. 2012;99(11):1501–13.

    Article  CAS  PubMed  Google Scholar 

  6. Butala P, Divino CM. Surgical aspects of fulminant Clostridium difficile colitis. Am J Surg. 2010;200(1):131–5.

    Article  PubMed  Google Scholar 

  7. Stewart D, Hollenbeak C, Wilson M. Is colectomy for fulminant Clostridium difficile colitis life saving? A systematic review. Colorectal Dis. 2013;15(7):798–804.

    Article  CAS  PubMed  Google Scholar 

  8. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1–e48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kautza B, Zuckerbraun BS. The surgical management of complicated Clostridium Difficile infection: alternatives to colectomy. Surg Infect (Larchmt). 2016;17(3):337–42.

    Article  Google Scholar 

  10. Malamood M, Nellis E, Ehrlich AC, Friedenberg FK. Vancomycin enemas as adjunctive therapy for Clostridium difficile infection. J Clin Med Res. 2015;7(6):422.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. McPherson S, Rees CJ, Ellis R, Soo S, Panter SJ. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Dis Colon Rectum. 2006;49(5):640–5.

    Article  PubMed  Google Scholar 

  12. Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont J, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut. 1997;41(3):366–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Herpers BL, Vlaminckx B, Burkhardt O, Blom H, Biemond-Moeniralam HS, Hornef M, et al. Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection. Clin Infect Dis. 2009;48(12):1732–5.

    Article  CAS  PubMed  Google Scholar 

  14. Dudukgian H, Sie E, Gonzalez-Ruiz C, Etzioni DA, Kaiser AM. C. difficile colitis—predictors of fatal outcome. J Gastrointest Surg. 2010;14(2):315–22.

    Article  PubMed  Google Scholar 

  15. Byrn JC, Maun DC, Gingold DS, Baril DT, Ozao JJ, Divino CM. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg. 2008;143(2):150–4; discussion 5.

    Article  PubMed  Google Scholar 

  16. Pepin J, Vo TT, Boutros M, Marcotte E, Dial S, Dube S, et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum. 2009;52(3):400–5.

    Article  PubMed  Google Scholar 

  17. Dallas KB, Condren A, Divino CM. Life after colectomy for fulminant Clostridium difficile colitis: a 7-year follow up study. Am J Surg. 2014;207(4):533–9.

    Article  PubMed  Google Scholar 

  18. Sailhamer EA, Carson K, Chang Y, Zacharias N, Spaniolas K, Tabbara M, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg. 2009;144(5):433–9; discussion 9–40.

    Article  PubMed  Google Scholar 

  19. Ali SO, Welch JP, Dring RJ. Early surgical intervention for fulminant pseudomembranous colitis. Am Surg. 2008;74(1):20–6.

    PubMed  Google Scholar 

  20. Ferrada P, Callcut R, Zielinski MD, Bruns B, Yeh DD, Zakrison TL, et al. Loop ileostomy versus total colectomy as surgical treatment for Clostridium difficile–associated disease: an Eastern Association for the Surgery of Trauma multicenter trial. J Trauma Acute Care Surg. 2017;83(1):36–40.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Seder CW, Villalba MR, Robbins J, Ivascu FA, Carpenter CF, Dietrich M. Early colectomy may be associated with improved survival in fulminant Clostridium difficile colitis: an 8-year experience. Am J Surg. 2009;197(3):302–7.

    Article  PubMed  Google Scholar 

  22. Lamontagne F, Labbe AC, Haeck O, Lesur O, Lalancette M, Patino C, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245(2):267–72.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235(3):363–72.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Miller AT, Tabrizian P, Greenstein AJ, Dikman A, Byrn J, Divino C. Long-term follow-up of patients with fulminant Clostridium difficile colitis. J Gastrointest Surg. 2009;13(5):956–9.

    Article  PubMed  Google Scholar 

  25. Markelov A, Livert D, Kohli H. Predictors of fatal outcome after colectomy for fulminant Clostridium difficile colitis: a 10-year experience. dr.markelov@gmail.com. Am Surg. 2011;77(8):977–80.

    PubMed  Google Scholar 

  26. Stokes AL, Bible A, Hollenbeak CS, Stewart DB Sr. Clostridium difficile infection is associated with lower inpatient mortality when managed by GI surgeons. Dis Colon Rectum. 2016;59(9):855–61.

    Article  PubMed  Google Scholar 

  27. Neal MD, Alverdy JC, Hall DE, Simmons RL, Zuckerbraun BS. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011;254(3):423–7; discussion 7–9.

    Article  PubMed  Google Scholar 

  28. Hall JF, Berger D. Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management. Am J Surg. 2008;196(3):384–8.

    Article  PubMed  Google Scholar 

  29. ClinicalTrials.gov. Loop ileostomy with colonic lavage for fulminant Clostridium difficile colitis. 2017. Available from: https://clinicaltrials.gov/show/NCT02347280.

  30. Turnbull RB Jr, Hawk WA, Weakley FL. Surgical treatment of toxic megacolon. Ileostomy and colostomy to prepare patients for colectomy. Am J Surg. 1971;122(3):325–31.

    Article  PubMed  Google Scholar 

  31. ClinicalTrials.gov. Intestinal lavage for the treatment of severe C. difficile infections. 2015. Available from: https://clinicaltrials.gov/ct2/show/NCT02466698.

  32. Eiseman Á, Silen W, Bascom G, Kauvar A. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44(5):854–9.

    CAS  PubMed  Google Scholar 

  33. Van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–15.

    Article  CAS  PubMed  Google Scholar 

  34. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013;108(4):500.

    Article  PubMed  Google Scholar 

  35. Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015;41(9):835–43.

    Article  CAS  PubMed  Google Scholar 

  36. Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann Intern Med. 2016;165(9):609–16.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478–98; quiz 99.

    Article  CAS  PubMed  Google Scholar 

  38. Fischer M, Sipe B, Rogers N, Cook G, Robb B, Vuppalanchi R, et al. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Aliment Pharmacol Ther. 2015;42(4):470–6.

    Article  CAS  PubMed  Google Scholar 

  39. Ianiro G, Masucci L, Quaranta G, Simonelli C, Lopetuso L, Sanguinetti M, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions. Aliment Pharmacol Ther. 2018;48(2):152–9.

    Article  CAS  PubMed  Google Scholar 

  40. Aroniadis OC, Brandt LJ, Greenberg A, Borody T, Kelly CR, Mellow M, et al. Long-term follow-up study of fecal microbiota transplantation for severe and/or complicated Clostridium difficile infection. J Clin Gastroenterol. 2016;50(5):398–402.

    PubMed  Google Scholar 

  41. Zainah H, Hassan M, Shiekh-Sroujieh L, Hassan S, Alangaden G, Ramesh M. Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection. Dig Dis Sci. 2015;60(1):181–5.

    Article  PubMed  Google Scholar 

  42. Hocquart M, Lagier JC, Cassir N, Saidani N, Eldin C, Kerbaj J, et al. Early fecal microbiota transplantation improves survival in severe Clostridium difficile infections. Clin Infect Dis. 2018;66(5):645–50.

    Article  CAS  PubMed  Google Scholar 

  43. Shogbesan O, Poudel DR, Victor S, Jehangir A, Fadahunsi O, Shogbesan G, et al. A systematic review of the efficacy and safety of fecal microbiota transplant for Clostridium difficile infection in immunocompromised patients. Can J Gastroenterol Hepatol. 2018;2018:1394379.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Lin SC, Alonso CD, Moss AC. Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature. Transpl Infect Dis. 2018;20:e12967.

    Article  PubMed  Google Scholar 

  46. Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539–48.

    Article  CAS  PubMed  Google Scholar 

  47. Brandt LJ. American Journal of Gastroenterology Lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol. 2013;108(2):177.

    Article  PubMed  Google Scholar 

  48. Allegretti JR, Kearney S, Li N, Bogart E, Bullock K, Gerber GK, et al. Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles. Aliment Pharmacol Ther. 2016;43(11):1142–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol. 2016;13(9):508.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Weingarden AR, Dosa PI, DeWinter E, Steer CJ, Shaughnessy MK, Johnson JR, et al. Changes in colonic bile acid composition following fecal microbiota transplantation are sufficient to control Clostridium difficile germination and growth. PLoS One. 2016;11(1):e0147210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9(12):1044–9.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, et al. Systematic review: adverse events of fecal microbiota transplantation. PLoS One. 2016;11(8):e0161174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Fischer M, Sipe B, Cheng Y-W, Phelps E, Rogers N, Sagi S, et al. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: a promising treatment approach. Gut Microbes. 2017;8(3):289–302.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mount Sinai Hospital, The Dr. Henry D. Janowitz Division of Gastroenterology, New York, NY, USA

    Ari Grinspan

  2. Icahn School of Medicine at Mount Sinai, The Dr. Henry D. Janowitz Division of Gastroenterology, New York, NY, USA

    Ari Grinspan

  3. Jewish General Hospital, Division of Colorectal Surgery, Montreal, QC, Canada

    Marylise Boutros

  4. McGill University, Department of Surgery, Montreal, QC, Canada

    Marylise Boutros

Authors
  1. Ari Grinspan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marylise Boutros
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA

    Patricia Sylla

  2. Keck School of Medicine of USC, Los Angeles, CA, USA

    Andreas M. Kaiser

  3. Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA

    Daniel Popowich

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Grinspan, A., Boutros, M. (2020). Organ-Preserving Strategies in the Management of Fulminant Clostridium difficile Colitis. In: Sylla, P., Kaiser, A., Popowich, D. (eds) The SAGES Manual of Colorectal Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-24812-3_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24812-3_35

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24811-6

  • Online ISBN: 978-3-030-24812-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation